Global Rifampicin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Rifampicin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Rifampicin, also known as rifampin, is an antibiotic used to treat several types of bacterial infections, including tuberculosis, mycobacterium avium complex, leprosy, and Legionnaire's disease. Common side effects include nausea, vomiting, diarrhea, and loss of appetite.
Rifampicin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rifampicin market is projected to reach US$ 193 million in 2029, increasing from US$ 124 million in 2022, with the CAGR of 6.4% during the period of 2024 to 2029. Demand from Tuberculosis and Leprosy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Rifampicin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Rifampicin key manufacturers include Sanofi, Wellona Pharma, AVANSCURE LIFESCIENCES, Hebei Xingang Pharmaceutical, Mercator Pharmaceutical Solutions and ASIAN PHARMACY, etc. Sanofi, Wellona Pharma, AVANSCURE LIFESCIENCES are top 3 players and held % sales share in total in 2022.
Rifampicin can be divided into Oral and Intravenous Injection, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Rifampicin is widely used in various fields, such as Tuberculosis, Leprosy, Legionnaire's Disease and Others, etc. Tuberculosis provides greatest supports to the Rifampicin industry development. In 2022, global % sales of Rifampicin went into Tuberculosis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rifampicin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi
Wellona Pharma
AVANSCURE LIFESCIENCES
Hebei Xingang Pharmaceutical
Mercator Pharmaceutical Solutions
ASIAN PHARMACY
Segment by Type
Oral
Intravenous Injection
Tuberculosis
Leprosy
Legionnaire's Disease
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rifampicin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rifampicin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rifampicin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rifampicin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rifampicin introduction, etc. Rifampicin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Rifampicin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Rifampicin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rifampicin market is projected to reach US$ 193 million in 2029, increasing from US$ 124 million in 2022, with the CAGR of 6.4% during the period of 2024 to 2029. Demand from Tuberculosis and Leprosy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Rifampicin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Rifampicin key manufacturers include Sanofi, Wellona Pharma, AVANSCURE LIFESCIENCES, Hebei Xingang Pharmaceutical, Mercator Pharmaceutical Solutions and ASIAN PHARMACY, etc. Sanofi, Wellona Pharma, AVANSCURE LIFESCIENCES are top 3 players and held % sales share in total in 2022.
Rifampicin can be divided into Oral and Intravenous Injection, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Rifampicin is widely used in various fields, such as Tuberculosis, Leprosy, Legionnaire's Disease and Others, etc. Tuberculosis provides greatest supports to the Rifampicin industry development. In 2022, global % sales of Rifampicin went into Tuberculosis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rifampicin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi
Wellona Pharma
AVANSCURE LIFESCIENCES
Hebei Xingang Pharmaceutical
Mercator Pharmaceutical Solutions
ASIAN PHARMACY
Segment by Type
Oral
Intravenous Injection
Segment by Application
Tuberculosis
Leprosy
Legionnaire's Disease
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rifampicin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rifampicin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rifampicin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rifampicin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rifampicin introduction, etc. Rifampicin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Rifampicin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices